| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▼ | 1.50▼ | 1.50▼ | 1.46▼ | 1.23▲ |
| MA10 | 1.53▼ | 1.52▼ | 1.51▼ | 1.35▲ | 1.30▲ |
| MA20 | 1.53▼ | 1.45▲ | 1.42▲ | 1.25▲ | 1.37▼ |
| MA50 | 1.41▲ | 1.31▲ | 1.28▲ | 1.31▲ | 1.35▲ |
| MA100 | 1.29▲ | 1.25▲ | 1.30▲ | 1.40▼ | 1.69▼ |
| MA200 | 1.25▲ | 1.35▲ | 1.37▲ | 1.43▼ | 2.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.019▼ | -0.009▼ | -0.005▼ | 0.035▲ | -0.008▼ |
| RSI | 47.805▼ | 58.096▲ | 59.664▲ | 54.892▲ | 50.380▲ |
| STOCH | 27.024 | 47.778 | 53.391 | 76.725 | 22.715 |
| WILL %R | -85.714▼ | -57.143 | -53.333 | -43.620 | -52.239 |
| CCI | -143.916▼ | -23.318 | -9.134 | 54.617 | 52.432 |
|
Thursday, August 27, 2026 01:10 PM
Research productivity and cash generation remain important operating signals. Merck remains under focus as oncology momentum, pipeline development, research productivity, commercial execution and cash ...
|
|
Wednesday, August 26, 2026 08:06 AM
Melanoma therapy data strengthens pipeline momentum. Personalized cancer treatment reaches a milestone. Portfolio diversification remains strategically important. Personalized cancer therapy is moving ...
|
|
Tuesday, August 25, 2026 03:22 AM
Merck & Co., Inc. (NYSE:MRK) jumped 12.6% to a record $152.20 on August 19 after a pivotal melanoma trial validated intismeran autogene, the individualized mRNA cancer therapy developed with Moderna.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/08/26 | 1.50 | 1.50 | 1.35 | 1.37 | 84,406 |
| 27/08/26 | 1.45 | 1.50 | 1.4001 | 1.46 | 24,506 |
| 26/08/26 | 1.52 | 1.5905 | 1.45 | 1.45 | 33,826 |
| 25/08/26 | 1.50 | 1.59 | 1.475 | 1.52 | 146,617 |
| 24/08/26 | 1.46 | 1.50 | 1.46 | 1.495 | 236,307 |
| 21/08/26 | 1.25 | 1.4399 | 1.25 | 1.39 | 99,043 |
| 20/08/26 | 1.28 | 1.2863 | 1.19 | 1.22 | 79,707 |
| 19/08/26 | 1.19 | 1.36 | 1.175 | 1.29 | 230,069 |
| 18/08/26 | 1.15 | 1.18 | 1.15 | 1.15 | 46,021 |
| 17/08/26 | 1.179 | 1.20 | 1.15 | 1.16 | 41,846 |
|
|
||||
|
|
||||
|
|